261 related articles for article (PubMed ID: 18311786)
1. Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin.
Singh S; Satishchandra P; Shankar SK; Ganesh S
Hum Mutat; 2008 Jun; 29(6):E1-12. PubMed ID: 18311786
[TBL] [Abstract][Full Text] [Related]
2. Modulation of functional properties of laforin phosphatase by alternative splicing reveals a novel mechanism for the EPM2A gene in Lafora progressive myoclonus epilepsy.
Dubey D; Ganesh S
Hum Mol Genet; 2008 Oct; 17(19):3010-20. PubMed ID: 18617530
[TBL] [Abstract][Full Text] [Related]
3. Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism.
Couarch P; Vernia S; Gourfinkel-An I; Lesca G; Gataullina S; Fedirko E; Trouillard O; Depienne C; Dulac O; Steschenko D; Leguern E; Sanz P; Baulac S
J Mol Med (Berl); 2011 Sep; 89(9):915-25. PubMed ID: 21505799
[TBL] [Abstract][Full Text] [Related]
4. Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes.
Singh S; Ganesh S
Hum Mutat; 2009 May; 30(5):715-23. PubMed ID: 19267391
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population.
Singh S; Suzuki T; Uchiyama A; Kumada S; Moriyama N; Hirose S; Takahashi Y; Sugie H; Mizoguchi K; Inoue Y; Kimura K; Sawaishi Y; Yamakawa K; Ganesh S
J Hum Genet; 2005; 50(7):347-352. PubMed ID: 16021330
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of novel splice variants of the human EPM2A gene mutated in Lafora progressive myoclonus epilepsy.
Dubey D; Parihar R; Ganesh S
Genomics; 2012 Jan; 99(1):36-43. PubMed ID: 22036712
[TBL] [Abstract][Full Text] [Related]
7. Interdependence of laforin and malin proteins for their stability and functions could underlie the molecular basis of locus heterogeneity in Lafora disease.
Mittal S; Upadhyay M; Singh PK; Parihar R; Ganesh S
J Biosci; 2015 Dec; 40(5):863-71. PubMed ID: 26648032
[TBL] [Abstract][Full Text] [Related]
8. Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells.
Zeng L; Wang Y; Baba O; Zheng P; Liu Y; Liu Y
FEBS J; 2012 Jul; 279(14):2467-78. PubMed ID: 22578008
[TBL] [Abstract][Full Text] [Related]
9. Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora disease.
Lesca G; Boutry-Kryza N; de Toffol B; Milh M; Steschenko D; Lemesle-Martin M; Maillard L; Foletti G; Rudolf G; Nielsen JE; á Rogvi-Hansen B; Erdal J; Mancini J; Thauvin-Robinet C; M'Rrabet A; Ville D; Szepetowski P; Raffo E; Hirsch E; Ryvlin P; Calender A; Genton P
Epilepsia; 2010 Sep; 51(9):1691-8. PubMed ID: 20738377
[TBL] [Abstract][Full Text] [Related]
10. Lafora progressive myoclonus epilepsy: recent insights into cell degeneration.
Spuch C; Ortolano S; Navarro C
Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):99-107. PubMed ID: 22369717
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.
Ganesh S; Delgado-Escueta AV; Suzuki T; Francheschetti S; Riggio C; Avanzini G; Rabinowicz A; Bohlega S; Bailey J; Alonso ME; Rasmussen A; Thomson AE; Ochoa A; Prado AJ; Medina MT; Yamakawa K
Hum Mol Genet; 2002 May; 11(11):1263-71. PubMed ID: 12019207
[TBL] [Abstract][Full Text] [Related]
12. Loss of function of the cytoplasmic isoform of the protein laforin (EPM2A) causes Lafora progressive myoclonus epilepsy.
Ianzano L; Young EJ; Zhao XC; Chan EM; Rodriguez MT; Torrado MV; Scherer SW; Minassian BA
Hum Mutat; 2004 Feb; 23(2):170-176. PubMed ID: 14722920
[TBL] [Abstract][Full Text] [Related]
13. Four novel and two recurrent NHLRC1 (EPM2B) and EPM2A gene mutations leading to Lafora disease in six Turkish families.
Salar S; Yeni N; Gündüz A; Güler A; Gökçay A; Velioğlu S; Gündoğdu A; Hande Çağlayan S
Epilepsy Res; 2012 Feb; 98(2-3):273-6. PubMed ID: 22047982
[TBL] [Abstract][Full Text] [Related]
14. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.
Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S
Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386
[TBL] [Abstract][Full Text] [Related]
15. Impaired malin expression and interaction with partner proteins in Lafora disease.
Skurat AV; Segvich DM; Contreras CJ; Hu YC; Hurley TD; DePaoli-Roach AA; Roach PJ
J Biol Chem; 2024 May; 300(5):107271. PubMed ID: 38588813
[TBL] [Abstract][Full Text] [Related]
16. Mutations in NHLRC1 cause progressive myoclonus epilepsy.
Chan EM; Young EJ; Ianzano L; Munteanu I; Zhao X; Christopoulos CC; Avanzini G; Elia M; Ackerley CA; Jovic NJ; Bohlega S; Andermann E; Rouleau GA; Delgado-Escueta AV; Minassian BA; Scherer SW
Nat Genet; 2003 Oct; 35(2):125-7. PubMed ID: 12958597
[TBL] [Abstract][Full Text] [Related]
17. Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes.
Ganesh S; Agarwala KL; Ueda K; Akagi T; Shoda K; Usui T; Hashikawa T; Osada H; Delgado-Escueta AV; Yamakawa K
Hum Mol Genet; 2000 Sep; 9(15):2251-61. PubMed ID: 11001928
[TBL] [Abstract][Full Text] [Related]
18. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease?
Puri R; Ganesh S
Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153
[TBL] [Abstract][Full Text] [Related]
19. Lafora progressive Myoclonus Epilepsy mutation database-EPM2A and NHLRC1 (EPM2B) genes.
Ianzano L; Zhang J; Chan EM; Zhao XC; Lohi H; Scherer SW; Minassian BA
Hum Mutat; 2005 Oct; 26(4):397. PubMed ID: 16134145
[TBL] [Abstract][Full Text] [Related]
20. A novel EPM2A mutation yields a slow progression form of Lafora disease.
Garcia-Gimeno MA; Rodilla-Ramirez PN; Viana R; Salas-Puig X; Brewer MK; Gentry MS; Sanz P
Epilepsy Res; 2018 Sep; 145():169-177. PubMed ID: 30041081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
